ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
News Oct 30, 2008
ZyGEM Corp. Ltd. has announced that it has entered into an agreement with the Advalytix product team of Olympus Life Science Research Europa GmbH to produce a private-label line of DNA extraction products.
The collaboration will combine ZyGEM’s advanced enzymatic nucleic acid extraction technology and Advalytix’s expertise in single-cell molecular tests for life science research and diagnostic applications.
ZyGEM’s DNA extraction technology uses a proprietary thermophilic enzyme to extract DNA from samples using a single closed-tube system. ZyGEM’s approach simplifies laboratory workflow, minimizes error, reduces the risk of contamination and ensures sample integrity, while also reducing costs.
The technology can be specifically formulated for use with a wide range of different sample types without the need for further purification. ZyGEM’s technology has been validated for use in research, forensic, diagnostic, agriculture and animal health applications.
Advalytix will market private-label DNA extraction products based on ZyGEM’s temperature-controlled extraction (TEC) technology. The kits are designed to work with Advalytix’s single-cell molecular diagnostics and its miniaturized diagnostic and biological tests for research and development.
Advalytix is Olympus’ division focusing on cell-based molecular biology. Advalytix’s products link imaging technologies such as microscopy with nucleic acid analysis, enabling fully integrated solutions with optimized instruments and reagents.
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.